Richmond Pharmacology is recognised globally by sponsors and CROs alike for its competence in patient recruitment.
Efficient recruitment in one place
10 for the price of 1We have the capacity to replace multiple sites confirmed by our rapid and on-time recruitment.The power of foresightOur recruitment database of over 200,000 healthy and patient trial seekers provides in depth insight into study feasibility for streamlined study designs, saving both time and cost.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.